Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Collegium Pharmaceutical

NASDAQ COLL
$33.29 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 33 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

1.38B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
1.81B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.05
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
41.44M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
8.15 %

Upcoming events Collegium Pharmaceutical

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Collegium Pharmaceutical

Stock analysis Collegium Pharmaceutical

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
14.79 8.79
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
7.06 25.38
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
5.37 4.40
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
1.27 0.50
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
41.99 9.54

Price change Collegium Pharmaceutical per year

17.24$ 26.91$
Min Max

Summary analysis Collegium Pharmaceutical

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Collegium Pharmaceutical

Revenue and net income Collegium Pharmaceutical

All parameters

Stock news Collegium Pharmaceutical

All news
3 January в 22:30

Collegium Pharmaceutical Shares Rise 11% After FY24 Guidance

3 January в 22:30

Collegium Pharmaceutical Shares Rise 11% After FY24 Guidance

4 January 2023 в 21:25

Collegium Pharmaceutical Shares Gain 11% on 2023 Guidance, Outlook

4 January 2023 в 21:25

Collegium Pharmaceutical Shares Gain 11% on 2023 Guidance, Outlook

15 February 2022 в 19:45

Collegium Pharmaceutical Inc. Shares Rise 12%, Extending Monday's Gains

15 February 2022 в 19:45

Collegium Pharmaceutical Inc. Shares Rise 12%, Extending Monday's Gains

14 February 2022 в 14:50

Collegium Pharmaceutical Buys BioDelivery Sciences for $5.60 a Share

14 February 2022 в 14:50

Collegium Pharmaceutical Buys BioDelivery Sciences for $5.60 a Share

16 August 2021 в 20:44

Collegium Pharmaceutical Up 12% After Buyback Program

16 August 2021 в 18:24

Collegium Pharmaceutical Authorizes $100M Share Buyback Program

7 November 2019 в 18:58

ЛИДЕРЫ УОЛЛ-СТРИТ-Qualcomm, Ralph Lauren, Invacare Corp, Collegium Pharmaceutical

About company Collegium Pharmaceutical

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Address:
100 Technology Center Drive, Stoughton, MA, United States, 02072
Company name: Collegium Pharmaceutical
Issuer ticker: COLL
ISIN: US19459J1043
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2015-05-07
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.collegiumpharma.com

On which stock exchange are Collegium Pharmaceutical (COLL) stocks traded?

Collegium Pharmaceutical (COLL) stocks are traded on NASDAQ.

What is the ticker of Collegium Pharmaceutical stocks (COLL)?

The stock ticker of Collegium Pharmaceutical’s stocks or in other words, the code is COLL. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Collegium Pharmaceutical (COLL) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Collegium Pharmaceutical (COLL) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Collegium Pharmaceutical (COLL) stocks traded?

Collegium Pharmaceutical (COLL) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Collegium Pharmaceutical (COLL) stocks today?

The current price of Collegium Pharmaceutical stocks on 15.05.2024 is 33.29 dollars. per share.

What is the dynamics of Collegium Pharmaceutical (COLL) stocks from the beginning of the year?

Collegium Pharmaceutical (COLL) quotes have increased by 6.6% from the beginning of the year up to 33.29 dollars. per 1 stocks.

How much did Collegium Pharmaceutical (COLL) stocks increase in мае 2024?

This month Collegium Pharmaceutical (COLL) quotes have increased by -11.88% to 33.29 dollars. per share.

How much are Collegium Pharmaceutical (COLL) stocks worth?

Today, on October, 15.05.2024 Collegium Pharmaceutical’s (COLL) stocks cost 33.29 dollars..

What is the market capitalization of Collegium Pharmaceutical (COLL)?

Capitalization is the market value of Collegium Pharmaceutical (COLL) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 15.05.2024, the market capitalization of Collegium Pharmaceutical (COLL) is estimated at about 1379486533 dollars.